Partex.AI Data enables Pharma, CROs and healthcare providers to accelerate innovation through high-quality Real-World Data, advanced AI services, and data-driven trial support tools
Traditional control arm design is impractical for rare diseases and ethically challenging to implement for providing a comparison group
Generate virtual patients based on clinical data distribution
Solution:
Facilitates trial design with regard to patient population
Insights into various aspects of patient demographics, disease prevalence
Solution:
Identify sites with a suitable patient population
Identify relevant biomarkers in patient data
Solution:
More precise disease diagnosis, prognosis, and treatment selection
Compare the outcomes of drugs against competitors
Solution:
Support evidence-based decision-making by healthcare providers
Provide safety monitoring and pharmacovigilance
Solution:
Support to detect and assess adverse events, monitor long-term safety, and evaluate the real-world effectiveness of their drugs
Evaluate the cost-effectiveness & impact on healthcare utilization
Solution:
Support for market access negotiations and reimbursement decisions
Provide insights into patient behaviors, treatment patterns, and unmet medical needs in the market
Solution:
Support in refining commercialization strategies
Provide validated and labelled training datasets
Solution:
Support supervised learning models
Diagnosis, treatments, lab results, ECOG scores, adverse events, survival outcomes
Offering insights into outcomes, patient profiles, and real-world effectiveness
Radiology and pathology reports, DICOM images
Somatic mutations, sequencing reports, relevant biomarkers
Line of therapy, dosage, combinations, progression
Progression-free survival (PFS), overall survival (OS), treatment response, patient-reported outcomes
Talk to us to explore licensing, partnerships, or how AI can reshape your drug pipeline